FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels

Objective To evaluate the usefulness of [18F]fluorodeoxyglucose (FDG) positron emissive tomography (PET)/CT in patients with low detectable thyroglobulin levels suspicious for persistent or recurrent differentiated thyroid cancer (DTC). Methods A retrospective case series study evaluating FDG PET/CT...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of endocrinology 2022-07, Vol.187 (1), p.101-110
Hauptverfasser:	Lebbink, Chantal A, de Vries, Lisa H, Borel Rinkes, Inne H M, Braat, Arthur J A T, van Leeuwaarde, Rachel S, Lodewijk, Lutske, van Treijen, Mark J C, Vriens, Menno R, Valk, Gerlof D, van Santen, Hanneke M, de Keizer, Bart
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Fluorodeoxyglucose F18 Humans Iodine Radioisotopes Lymph nodes Metastases Metastasis Neoplasm Recurrence, Local - pathology Original Patients Positron emission tomography Positron Emission Tomography Computed Tomography Retrospective Studies Thyroglobulin Thyroid cancer Thyroid Neoplasms - diagnostic imaging Thyroid Neoplasms - pathology Thyroid Neoplasms - surgery Thyroidectomy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective To evaluate the usefulness of [18F]fluorodeoxyglucose (FDG) positron emissive tomography (PET)/CT in patients with low detectable thyroglobulin levels suspicious for persistent or recurrent differentiated thyroid cancer (DTC). Methods A retrospective case series study evaluating FDG PET/CT in patients with detectable thyroglobulin (Tg) levels (≥0.20 and
ISSN:	0804-4643 1479-683X
DOI:	10.1530/EJE-22-0072